Table 2. Changes of each blood test.
| T-cho (mg/dL) | Pre | 1M | 2M | 3M | 4M | 5M | 6M |
|---|---|---|---|---|---|---|---|
| Febuxostat | 159.3 ± 4.7 | 160.5 ± 4.4 | 167.6 ± 4.1 | 165.4 ± 5.5 | 167.9 ± 5.0 | 164.4 ± 4.8 | 159.5 ± 4.5 |
| Topiroxostat | 166.3 ± 5.2 | 163.6 ± 5.2 | 164.0 ± 5.1 | 164.6 ± 4.6 | 167.2 ± 5.0 | 163.1 ± 4.9 | 162.6 ± 5.4 |
| TG (mg/dL) | Pre | 1M | 2M | 3M | 4M | 5M | 6M |
| Febuxostat | 118.8 ± 8.5 | 114.8 ± 7.5 | 116.8 ± 8.3 | 119.0 ± 8.8 | 114.4 ± 6.8 | 117.0 ± 8.0 | 105.0 ± 7.4 |
| Topiroxostat | 135.7 ± 13.3 | 139.2 ± 14.2 | 121.0 ± 9.3 | 139.6 ± 12.7 | 119.4 ± 8.0 | 111.3 ± 7.8 | 122.9 ± 9.1 |
| L/H | Pre | 1M | 2M | 3M | 4M | 5M | 6M |
| Febuxostat | 1.67 ± 0.10 | 1.64 ± 0.10 | 1.64 ± 0.10 | 1.61 ± 0.10 | 1.63 ± 0.10 | 1.61 ± 0.10 | 1.60 ± 0.10 |
| Topiroxostat | 1.74 ± 0.11 | 1.71 ± 0.10 | 1.71 ± 0.10 | 1.75 ± 0.12 | 1.74 ± 0.13 | 1.63 ± 0.11 | 1.66 ± 0.10 |
| RLP-cho(mg/dL) | Pre | 3M | 6M | ||||
| Febuxostat | 4.97 ± 0.58 | – | – | 4.99 ± 0.59 | – | – | 4.14 ± 0.50 |
| Topiroxostat | 4.87 ± 0.59 | – | – | 5.21 ± 0.59 | – | – | 4.57 ± 0.46 |
| EPA/AA | Pre | 3M | 6M | ||||
| Febuxostat | 0.53 ± 0.06 | – | – | 0.60 ± 0.07 | – | – | 0.61 ± 0.07 |
| Topiroxostat | 0.63 ± 0.06 | – | – | 0.62 ± 0.07 | – | – | 0.58 ± 0.06 |
| BNP (pg/mL) | Pre | 3M | 6M | ||||
| Febuxostat | 124.1 ± 29.3 | – | – | 108.4 ± 26.5 | – | – | 110.6 ± 29.9 |
| Topiroxostat | 116.6 ± 0.04 | – | – | 125.3 ± 31.7 | – | – | 149.8 ± 36.4 |
| hs-CRP (mg/dL) | Pre | 1M | 2M | 3M | 4M | 5M | 6M |
| Febuxostat | 0.21 ± 0.06 | 0.38 ± 0.19 | 0.23 ± 0.04 | 0.19 ± 0.03 | 0.28 ± 0.08 | 0.32 ± 0.07 | 0.23 ± 0.05 |
| Topiroxostat | 0.19 ± 0.03 | 0.23 ± 0.05 | 0.33 ± 0.09 | 0.30 ± 0.09 | 0.24 ± 0.07 | 0.41 ± 0.17 | 0.31 ± 0.07 |
BNP: B-type natriuretic peptide; hs-CRP: high-sensitivity C-reactive protein; T-cho: total cholesterol; TG: triglyceride; L/H: high-density lipoprotein/low-density lipoprotein; RLP-cho: remnant-like particles-cholesterol; EPA/AA: eicosapentaenoic acid/arachidonic acid